Annexin Pharmaceuticals AB (ANNX) — Financial Flexibility Index
Annexin Pharmaceuticals AB (ANNX) has a Financial Flexibility Index of -1.86x as of March 2026. Free cash flow of Skr-10.33 Million (operating CF Skr-10.33 Million minus capex Skr0.00) represents -2% of total liabilities (Skr5.56 Million). Check ANNX PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Annexin Pharmaceuticals AB Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Annexin Pharmaceuticals AB across 11 annual periods. See Annexin Pharmaceuticals AB current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Annexin Pharmaceuticals AB (2015–2025)
Year-by-year free cash flow to debt coverage for Annexin Pharmaceuticals AB. For the full company profile including market capitalisation, see Annexin Pharmaceuticals AB (ANNX) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -7.04x | Skr-36.80 Million | Skr-36.92 Million | Skr5.22 Million | ▲ +25.4% |
| 2024 | -9.44x | Skr-50.23 Million | Skr-50.23 Million | Skr5.32 Million | — |
| 2023 | 0.00x | Skr0.00 | Skr-43.40 Million | Skr7.95 Million | ▲ +100.0% |
| 2022 | -6.31x | Skr-41.16 Million | Skr-41.16 Million | Skr6.53 Million | ▲ +15.1% |
| 2021 | -7.43x | Skr-45.02 Million | Skr-45.02 Million | Skr6.06 Million | ▲ +14.3% |
| 2020 | -8.67x | Skr-39.20 Million | Skr-39.20 Million | Skr4.52 Million | ▼ -53.3% |
| 2019 | -5.66x | Skr-25.73 Million | Skr-25.73 Million | Skr4.55 Million | ▼ -23.0% |
| 2018 | -4.60x | Skr-28.45 Million | Skr-28.50 Million | Skr6.19 Million | ▲ +24.3% |
| 2017 | -6.07x | Skr-38.93 Million | Skr-39.08 Million | Skr6.41 Million | ▼ -381.4% |
| 2016 | -1.26x | Skr-9.95 Million | Skr-9.95 Million | Skr7.88 Million | ▲ +13.8% |
| 2015 | -1.46x | Skr-4.80 Million | Skr-5.01 Million | Skr3.28 Million | — |